Call for Abstract

6th Global Experts Meeting on Cardiology and Cardiovascular Pharmacology, will be organized around the theme “Drugs Affecting the Rhythm of Heart”

Cardiac Pharmacology 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cardiac Pharmacology 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Heart is a muscular organ; it is size of a closed fist. Responsibility of heart is pumping blood through the blood vessels by recurrent, rhythmic contractions. The heart is consisting of cardiac muscle, an involuntary muscle tissue. The term "cardiac" means "related to the heart”. It is a four-chambered, double pump and is located in the thoracic cavity between the lungs. The cardiac muscle is own conduction system. This is in contrast with skeletal muscle, which requires either conscious or reflex nervous stimuli. The heart's rhythmic contractions occur instinctively, although heart rate can be changed by nervous or hormonal influence such as exercise or the perception of danger.

  • Track 1-1Cardiac Anatomy and Physiology
  • Track 1-2Cardiovascular System
  • Track 1-3Circulatory System

CVDs include diseases of the heart, vascular diseases of the brain and diseases of blood vessels. CVDs are responsible for over 17.3 million deaths per year and are the leading causes of death in the world .The different types of CVDs are listed below.

Atherosclerosis: Ischaemic heart disease or coronary artery disease, Cerebrovascular disease, Diseases of the aorta and arteries, including hypertension and peripheral vascular disease. Other CVDs  are Congenital heart disease, Rheumatic heart disease, Cardiomyopathies, Cardiac arrhythmias.

Coronary Heart DiseaseCoronary Heart Disease (CHD) is the most common form of heart disease. It occurs when the arteries supplying blood to the heart narrow or harden from the build-up of plaque. Plaque is made up of fat, cholesterol and other substances found in the blood. The location of the plaque determines the type of heart disease.

  • Track 2-1Atherosclerosis
  • Track 2-2Congenital heart disease
  • Track 2-3Rheumatic heart disease
  • Track 2-4Cardiomyopathies
  • Track 2-5Cardiac arrhythmias
  • Track 2-6Chagas disease

Cardiovascular Pharmacotherapy: It includes Treatment for Cardiovascular disease such as medication, surgery and other procedures. Cardiovascular disease treatments vary by condition. If one has a heart infection, he/she likely is given antibiotics. In general, treatment for heart disease commonly includes: Lifestyle changes like doing exercise regularly, maintaining a proper diet chat, Medications, surgery or Medical procedures. The aims of treatment are to relieve symptoms, lower the risk of blood clots forming, bring down risk factors in an effort to slow, stop, or reverse the build-up of plaque. To Prevent Cardiovascular Disease complications we have to get updated with the treatments of cardiovascular diseases and to do so we will organize Cardiology Conferences every year worldwide.

  • Track 3-1Cardiovascular Drugs
  • Track 3-2Heart Transplant
  • Track 3-3Cardiomyoplasty
  • Track 3-4Bypass Surgery
  • Track 3-5Artificial Heart Valve Surgery
  • Track 3-6Angioplasty
  • Track 3-7Open Heart Surgery
  • Track 3-8Drug Therapy for Systemic Hypertension
  • Track 3-9Anti-Ischemic Drug Therapy
  • Track 3-10Combination drug therapy
  • Track 3-11Pharmacokinetics and Pharmacodynamics of CVD Drugs
  • Track 3-12Different Techniques Used for Cardiac Surgeries

There are many risk factors associated with coronary heart disease and stroke. Some risk factors cannot be changed such as family history, ethnicity and age.  Other risk factors that can be treated or changed include tobacco exposure, high blood pressure (hypertension), high cholesterolobesity, physical inactivitydiabetesunhealthy diets, and harmful use of alcohol.

In developing countries people are struggling with increasing rates of cardiovascular disease, they still face the scourges of poor nutrition and infectious disease. Cardiovascular disease is the leading cause of death in the developing world. You will not necessarily develop cardiovascular disease if you have a risk factor.  But the more risk factors you have the greater is the likelihood that you will, unless you take action to modify your risk factors and work to prevent them compromising your heart health.

  • Track 4-1Behavioural risk factors
  • Track 4-2Metabolic risk factors
  • Track 4-3Other risk factors

Interventional cardiology is a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Andreas Gruentzig is considered the father of interventional cardiology after the development of angioplasty by interventional radiologist Charles Dotter.A large number of procedures can be performed on the heart by catheterization. This most commonly involves the insertion of a sheath into the femoral artery (but, in practice, any large peripheral artery or vein) and cannulating the heart under X-ray visualization (most commonly fluoroscopy). The radial artery may also be used for cannulation; this approach offers several advantages, including the accessibility of the artery in most patients, the easy control of bleeding even in anticoagulated patients, the enhancement of comfort because patients are capable of sitting up and walking immediately following the procedure, and the near absence of clinically significant sequelae in patients with a normal Allen test. The main advantages of using the interventional cardiology or radiology approach are the avoidance of the scars and pain, and long post-operative recovery. Additionally, interventional cardiology procedure of primary angioplasty is now the gold standard of care for an acute myocardial infarction. It involves the extraction of clots from occluded coronary arteries and deployment of stents and balloons through a small hole made in a major artery, which has given it the name "pin-hole surgery". This Cardiology conference or rather all cardiology conferences will help in networking, B2B partnering between professionals and academicians. Cardiology conferences, cardiac conferences are very important for the common people to be aware of the most important part of human body.

  • Track 5-1Percutaneous valve repair
  • Track 5-2Percutaneous valve replacement surgery
  • Track 5-3Coronary artery angioplasty and stenting
  • Track 5-4Carotid artery stenting
  • Track 5-5Vascular interventions for peripheral artery disease
  • Track 5-6Angioplasty catheters

Echocardiography is a diagnostic test that uses ultrasound waves to create an image of the heart muscle. Ultrasound waves that echo off the heart can show the size, shape, and movement of the heart's valves and chambers as well as the flow of blood through the heart. Echocardiography shows abnormalities as poorly functioning heart valves or damage to the heart tissue from a past heart attack. Echocardiography is used to diagnose certain cardiovascular diseases. In fact, it is one of the most widely used diagnostic tool for heart diseases. It can provide a wealth of helpful information of diseased condition of heart. The conference reaches out the vivid topics in the field of echocardiography. This Cardiac Pharmacology conference or rather all cardiology conferences will help in networking, B2B partnering between professionals and academicians. Cardiology conferences, cardiac conferences are very important for the common people to be aware of the most important part of human body.

Nuclear cardiology is non-invasive techniques to assess myocardial blood flow, evaluate the pumping function of the heart as well as visualize the size and location of a heart attack. Myocardial perfusion imaging is the most widely used technique of nuclear cardiology. Myocardial perfusion images are combined with exercise to assess the blood flow to the heart muscle. Exercise is most often in the form of walking on the treadmill. A "chemical" of "pharmacological" stress test using the drug dipyridamole, adenosine or dobutamine is performed in patients who are not able to exercise maximally, providing similar information about the heart's blood flow.

 Radionuclide ventriculography is a non-invasive study, about the pumping function of the heart. In coronary artery diseased, and in those who have had a heart attack, the assessment of the pumping function of the heart is essential in the prediction of both long term and short-term survival. The basic cellular component of the heart muscle may be irreversibly affected in the setting of a limited blood supply and or inflammation.

Nuclear cardiology techniques can be used to determine which areas of the heart muscle have been damaged by infection or by a heart attack. These techniques can also be used to monitor the status of the heart muscle in the patient after cardiac transplantation. This Cardiac pharmacology conference or rather all cardiology conferences will help in networking, B2B partnering between professionals and academicians. Cardiology conferences, cardiac conferences are very important for the common people to be aware of the most important part of human body.

  • Track 6-1Radionuclide myocardial perfusion imaging
  • Track 6-2Angiocardiography

Cerebral vascular disease is caused by atherosclerosis, that is the narrowing and blockage of the blood vessels that flow to the brain. If the flow of blood is cut off this can lead to strokes and transient ischemic attacks.Brain StrokeA stroke occurs when the blood supply to the brain is interrupted. It happens either when a blood vessel in the brain or neck is blocked or bursts or brain is deprived of oxygen and parts of brain may be permanently damaged. The consequences of a stroke can include problems with speech or vision, weakness or paralysis.Transient ischemic attacks Just as stroke occurs when the flow of blood is blocked, TIAs happen when there is a brief blockage. The temporary loss of blood to the brain causes a brief, sudden change in brain function.  This may manifest as temporary numbness or weakness on one side of the body, loss of balance, confusion, and blindness in one or both eyes, double vision, difficulty speaking, or a severe. But these will disappear quickly and permanent damage is unlikely.Dementia The additive effects of multiple small strokes, together with microangiopathy affecting the small blood vessels to the brain, lead to an increased likelihood of dementia in people with diabetes.

 

  • Track 7-1Neurological Diseases
  • Track 7-2Dementia
  • Track 7-3Transient ischemic
  • Track 7-4Neuro Stroke

Diabetes can lead to cardiovascular damage in a number of ways. The processes do not develop independently, as each may accelerate or worsen the others. Thus, as diabetes progresses, the heart and blood vessels are exposed to multiple attacks. The cardiovascular complications of diabetes are therefore a major cause of illness, death and healthcare costs. Cardiovascular death rates are either high or appear to be climbing in countries where diabetes is prevalent. When we consider that the number of people with diabetes around the world is predicted to double over the coming decades, the outlook for cardiovascular disease becomes even more alarming. The recent decline in cardiovascular disease in the USA, Australasia and Western Europe may be compromised significantly by this upsurge in diabetes. In other parts of the world where cardiovascular disease has been proliferating in recent years, the additional impact of diabetes threatens to have devastating consequences. High blood glucose in adults with diabetes increases the risk for heart attack, stroke, angina,   and coronary artery disease.

  •  People with type 2 diabetes also have high rates of high blood pressure, lipid problems, and obesity, which contribute to their high rates of CVD.
  • Smoking doubles the risk of CVD in people with diabetes.
  • Track 8-1Hypertension
  • Track 8-2Diabetes
  • Track 8-3Renal Diseases
  • Track 8-4Lipoprotein Disorders

Although CVD has sometimes been considered a disease that predominantly affects men, it is the leading cause of death among both men and women globally. There are number of notable gender differences in CVD incidence, mortality, risk-factor profiles, outcomes, and clinical presentation. These differences remain consistent across populations and regions and are thus important to consider when developing CVD prevention and treatment programs.

  • Track 9-1Pregnancy
  • Track 9-2Women
  • Track 9-3Paediatrics

Cardiologists are physicians or doctors who specialize in treating diseases or conditions of the heart and diagnosing the whole blood vessels i.e. cardiovascular system. One must visit a cardiologist so they can learn about their risk factors for Cardiac or heart disease and find out what measures should be taken for better heart health. When one is dealing with heart disease, it is important that they must find the right match between them and their specialist and for that, basic knowledge on cardiology is much needed. To make it possible Cardiology Conferences are organised to spread the awareness to control this heart related sufferings and problems.

Angiology is the medical specialty which studies the diseases of the circulatory system and of the lymphatic system, i.e., arteries, veins and lymphatic vases, and its diseases. Angiology is the field that deals with preventing, diagnosing and treating vascular and blood vessel related diseases.

  • Track 10-1Paediatric cardiologists
  • Track 10-2Non-invasive cardiologists
  • Track 10-3Cardiology consultants
  • Track 10-4Cardiac surgeons
  • Track 10-5Angiologists

As the 20th century era to a close, Cardiovascular disease (CVD) becomes a ubiquitous cause of morbidity and a principal contributor to mortality in most countries. The major risk factors through population-based studies and effective control approaches combining community education and targeted management of high risk individuals added to the fall in CVD mortality rates that observed in almost all industrialized & modernized countries.

  • Track 11-1Epidemiological Transition
  • Track 11-2Lifestyle Changes
  • Track 11-3Potential Effect of Impaired Fetal Nutrition
  • Track 11-4Nutrition Transition

Cardiotoxicity is the occurrence of heart electrophysiology dysfunction or muscle damage. The heart becomes weaker and is not as efficient in pumping and therefore circulating blood. Cardio toxicity may be caused by chemotherapy. Treatment, complications from anorexia nervosa, adverse effects of heavy metals intake, or an incorrectly administered drug such as bupivacaine. One of the ways to detect cardiotoxicity at early stages when there is a sub conical dysfunction is by measuring changes in regional function of the heart using strain.

  • Track 12-1Anorexia nervosa
  • Track 12-2Heavy metals
  • Track 12-3Chemotherapy

Stem cell therapy and tissue engineering represent a forefront of current research in the treatment of heart disease. With these technologies, advancements are being made into therapies for acute ischemic myocardial injury and chronic, otherwise non reversible, myocardial failure. The current clinical management of cardiac ischemia deals with re-establishing perfusion to the heart but not dealing with the irreversible damage caused by the occlusion or stenosis of the supplying vessels. The applications of these new technologies are not yet fully established as part of the management of cardiac diseases but will become so in the near future. The discussion presented here reviews some of the pioneering works at this new frontier. Key results of allogeneic and autologous stem cell trials are presented, including the use of embryonic, bone marrow-derived, adipose-derived, and resident cardiac stem cells.

  • Track 13-1Adipose tissue derived regenerative cells
  • Track 13-2Mobilization of progenitor cells
  • Track 13-3stem cells
  • Track 13-4Bone marrow derived stem cells
  • Track 13-5Cardiac derived stem cells
  • Track 13-6Quality of Care & Clinical Outcomes

Our all Cardiology conferences has Case Studies act as informative examples to people who might also faces similar problems. Generally, Case Studies in Cardiovascular disease, should detail a particular medical case, reporting the background of the patient. They should discuss investigations undertaken in order to determine a diagnosis or differentiate between possible diagnoses, and should indicate the type of treatment the patient underwent as a result. In one piece we can conclude that Case Studies is an useful and informative part of every doctor or physician's medical education.

  • Track 14-1An unexpected association between diseases or symptoms.
  • Track 14-2Findings that shed new light on the possible pathogenesis of a disease or an adverse effect.
  • Track 14-3Unique therapeutic approaches.
  • Track 14-4Intensive care units (ICU)

Cardiovascular nursing is a specialty that works with patients who suffer from numerous conditions of the cardiovascular system. Cardiovascular nurses facilitate treat conditions like unstable angina, myocardial infarction, cardiomyopathy, coronary artery disease, cardiac dysrhythmia and congestive heart failure under the direction of a heart specialist (cardiologist). Cardiovascular nurses perform postoperative care on a stress test evaluations, cardiac monitoring, surgical unit, health assessments and vascular monitoring. Cardiovascular nurses must have Advanced Cardiac Life Support and Basic Life Support certification. Cardiovascular nurses must possess specialized skills including defibrillation, electrocardiogram monitoring and medication administration by continuous intravenous drip. Cardiovascular nurses care for people with Cardiovascular disease and interact with their patients families. They may monitor and treat acutely ill patients, or they may focus on cardiovascular rehabilitation helping patients make lifestyle changes to prevent the worsening of their disease.

Coronary care units (CCU)

Intensive care units (ICU)

Clinical research

Cardiovascular intensive care units (CVICU)

  • Track 15-1Coronary care units (CCU)
  • Track 15-2Clinical research
  • Track 15-3Cardiovascular intensive care units

Clinical trials in cardiology research investigations are being conducted in which people of cardiac failures or disorders volunteer to test new treatments, interventions or tests as a means to prevent, detect, treat or manage various cardiovascular diseases or medical conditions. Some investigations look at how people respond to a new intervention and the side effects which might occur. This helps to determine if a new intervention works, if it is safe, and if it is better than the interventions that are already available. Clinical trials might also compare existing interventions, test new ways to use or combine existing interventions or observe how people respond to other factors that might affect their health such as dietary changes.

  • Track 16-1Clinical research models for coronary syndromes
  • Track 16-2Impediments to investment in cardiovascular research
  • Track 16-3Innovative approaches to cardiovascular drug development
  • Track 16-4Simple, practical approaches to conducting large randomized trials
  • Track 16-5Evidence gaps and limitations

We will examine recent variability and statistics regarding survival rates from cardiac arrest and industries related to Cardiovascular Medicine which will focus on challenging areas of research and it will assist us to steps ahead to improve the quality of care for cardiac problems like heart arrest etc. To meet the increasing demand for cardiovascular services and to ensure excellence in cardiac care delivery, on a series of upgrades and renovations that will enhance its ability to provide not only prompt also expert medical treatment, and even the best patient experience possible. This study will focus on the following topics: 3-D “Bioprinter, Information Technology, Thrombolytic [clot-busting] drug, Mobile Cardiovascular medicine apps, Social Media and Cardiovascular Medicine.

  • Track 17-1Reasons for the higher cost of drug development for cardiovascular as compared with other diseases
  • Track 17-2Drivers, restraints, and challenges shaping the Cardiovascular Drugs market dynamics
  • Track 17-3Latest innovations and key events in the industry
  • Track 17-4Analysis of business strategies of the top players
  • Track 17-5Cardiovascular Drugs market estimates and forecasts(2015 -2021)
  • Track 17-6Regulatory and health economic hurdles